Archive

Filter
  • July 19, 2013
  • Alert

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is a multinational specialty pharmaceutical companythat develops, manufactures and markets a broad range of products, primarily in dermatology, neurology and branded generics. Valeant has a $29 billion market capitalization. Some 70 percent of this Montreal-based company’s revenues come from the US and Canada,… Read More

  • July 12, 2013

Instead of investing like the hedge funds, it usually pays not to try to be so clever, as this week shows yet again. Read More

Just two months ago, Wall Street was saying it expected and even wanted the rally in stocks to undergo a “pause that refreshes.” Read More